Conference Call Scheduled for Wednesday, October 23 at 4:30 p.m. Eastern Time SAN DIEGO , Oct.
16, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will release financial results for the third quarter 2024 after the market close on Wednesday, October 23, 2024 . The company will host a conference call to discuss financial results and general corporate updates beginning at 4:30 p.
m. Eastern Time on Wednesday , October 23, 2024. To participate on the conference call, please dial (844) 850-0543 from the U.
S. or (412) 317-5199 from outside the U.S.
In addition, following the completion of the call, a telephone replay will be accessible until October 30, 2024 , by dialing (877) 344-7529 from the U.S. or (412) 317-0088 from outside the U.
S. and entering replay access code #9473630. Those interested in listening to the conference call live via the internet may do so by visiting the Webcasts page of Viking's website at http://ir.
vikingtherapeutics.com/webcasts . An archive of the webcast will also be available on the Webcasts page of the company's website for 30 days.
About Viking Therapeutics, Inc. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders,.
